ArticleAntimicrobial agents and chemotherapy2011

Replicative fitness costs of nonnucleoside reverse transcriptase inhibitor drug resistance mutations on HIV subtype C.

Kimberly L Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.